BUDGET IMPACT ANALYSIS OF ALEMTUZUMAB IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN HEALTHCARE SOCIAL SECURITY (ESSALUD) IN PERU

被引：0
|
作者：
Moreno, M. [1 ]
Arce, J. [1 ]
Cruz, A. [2 ]
Carpio Farro, R. [3 ]
机构：
[1] Sanofi Aventis Colombia, Bogota, Cun, Colombia
[2] Hosp Alberto Sabogal, Magdalena Del Mar, Peru
[3] Sanofi Aventis Peru, Lima, Peru
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND37
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [31] Influence of Alemtuzumab Treatment on Peripheral Mediators of Inflammation in Relapsing-Remitting Multiple Sclerosis Patients
    Studer, Valeria
    Ferri, Anna
    Perugini, Jacopo
    Clerici, Valentina Torri
    Confalonieri, Paolo
    Antozzi, Carlo
    Mantegazza, Renato
    Schilke, Edoardo
    Brambilla, Laura
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 25 - 26
  • [32] Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis
    Ladwig, A.
    Suh, J.
    Schweitzer, F.
    Roeth, P.
    Remke, G.
    Warnke, C.
    Schroeter, M.
    Izquierdo-Alvarez, E.
    Bonmann, E.
    Fink, G. R.
    Pallasch, C.
    Lehmann, H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 259 - 259
  • [33] BUDGET IMPACT ANALYSIS OF DELAYED-RELEASE DIMETHYLFUMARATE IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Furneri, G.
    Marchesi, C.
    Santoni, L.
    VALUE IN HEALTH, 2015, 18 (07) : A700 - A701
  • [34] Social cognition and Theory of Mind in patients with relapsing-remitting multiple sclerosis
    Banati, M.
    Sandor, J.
    Mike, A.
    Illes, E.
    Bors, L.
    Feldmann, A.
    Herold, R.
    Illes, Z.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) : 426 - 433
  • [35] Prevalence of social cognition disorders in relapsing-remitting multiple sclerosis patients
    Dodich, A.
    Realmuto, S.
    Cerami, C.
    Meli, R.
    Canessa, N.
    Ragonese, P.
    Salemi, G.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 : S42 - S42
  • [36] Social Cognition Impairments in Relapsing-Remitting Multiple Sclerosis
    Henry, Audrey
    Tourbah, Ayman
    Chaunu, Marie-Pierre
    Rumbach, Lucien
    Montreuil, Michele
    Bakchine, Serge
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2011, 17 (06) : 1122 - 1131
  • [37] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
    Agiela, Mabroka I. M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
  • [38] Impact of Pregnancy on the Course of Relapsing-Remitting Multiple Sclerosis
    Manganas, Alexandra
    Karp, Igor
    Roger, Elaine
    Duquette, Pierre
    NEUROLOGY, 2011, 76 (09) : A610 - A610
  • [39] The impact of pregnancy on progression of relapsing-remitting multiple sclerosis
    Karp, I.
    Manganas, A.
    Sylvestre, M. -P.
    Roger, E.
    Ho, A.
    Duquette, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 102 - 103
  • [40] Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
    María Rosario Blasco
    Antonio Ramos
    Celia García Malo
    Antonio García-Merino
    Journal of Neurology, 2017, 264 : 168 - 169
12345